Article ; Online: Latifolin protects against myocardial infarction by alleviating myocardial inflammatory via the HIF-1α/NF-κB/IL-6 pathway.
2020 Volume 58, Issue 1, Page(s) 1156–1166
Abstract: Context: The Traditional Chinese herb medicine : Objective: To investigate whether latifolin can improve myocardial infarction (MI) through attenuating myocardial inflammatory and to explore its possible mechanisms.: Materials and methods: Left ... ...
Abstract | Context: The Traditional Chinese herb medicine Objective: To investigate whether latifolin can improve myocardial infarction (MI) through attenuating myocardial inflammatory and to explore its possible mechanisms. Materials and methods: Left coronary artery was ligated to induce a rat model of MI, and the rats were treated with sodium carboxymethyl cellulose (CMC-Na) or different doses of latifolin (25, 50, 100 mg/kg/d) by oral gavage for 28 days. Serum contents of myocardial enzyme were measured at seven and fourteen days after treatment. Cardiac function, infarct size, histopathological changes and inflammatory cells infiltration was assessed at 28 days after treatment. Western blotting was used to investigate the underlying mechanisms. Results: Latifolin treatment markedly decreased the contents of myocardial enzymes, and increased left ventricular ejection fraction (85.27% vs. 59.11%) and left ventricular fractional shortening (62.71% vs. 45.53%). Latifolin was found to significantly reduced infarction size (27.78% vs. 39.07%), myocardial fibrosis and the numbers of macrophage infiltration (436 cells/mm Discussion and conclusions: Latifolin can protect against myocardial infarction by improving myocardial inflammation through the HIF-1α/NF-κB/IL-6 signalling pathway. Accordingly, latifolin may be a promising drug for pharmacological treatment of ischaemic cardiovascular disease. |
---|---|
MeSH term(s) | Animals ; Dalbergia/chemistry ; Enzymes/blood ; Heart Function Tests ; Hypoxia-Inducible Factor 1, alpha Subunit/drug effects ; Interleukin-6 ; Male ; Medicine, Chinese Traditional ; Myocardial Infarction/pathology ; Myocardial Infarction/prevention & control ; Myocarditis/drug therapy ; Myocarditis/pathology ; Myocardium/pathology ; NF-kappa B/drug effects ; Phenols/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Signal Transduction/drug effects ; Stroke Volume |
Chemical Substances | Enzymes ; Hif1a protein, rat ; Hypoxia-Inducible Factor 1, alpha Subunit ; Il6 protein, rat ; Interleukin-6 ; NF-kappa B ; Phenols ; latifolin |
Language | English |
Publishing date | 2020-11-22 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 1440131-9 |
ISSN | 1744-5116 ; 1388-0209 |
ISSN (online) | 1744-5116 |
ISSN | 1388-0209 |
DOI | 10.1080/13880209.2020.1840597 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 1300: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.